Tigecycline as a Second-Line Agent for Legionnaires’ Disease in Severely Ill Patients

por Slawek, Deepika, Altshuler, Diana, Dubrovskaya, Yanina, Louie, Eddie
Publicado 2017

Refractory Toxic Shock-Like Syndrome from Streptococcus dysgalactiae ssp. equisimilis and Intravenous Immunoglobulin as Salvage Therapy: A Case Series

por Islam, Marjan, Karter, Dennis, Altshuler, Jerry, Altshuler, Diana, Schwartz, David, Torregrossa, Gianluca
Publicado 2016

Outcomes of Cytomegalovirus Viremia Treatment in Critically Ill Patients With COVID-19 Infection

por Schoninger, Scott, Dubrovskaya, Yanina, Marsh, Kassandra, Altshuler, Diana, Prasad, Prithiv, Louie, Eddie, Weisenberg, Scott, Hochman, Sarah, Fridman, David, Trachuk, Polina
Publicado 2022

Low dose vs high dose tocilizumab in COVID-19 patients with hypoxemic respiratory failure

por Chung, Juri, Brosnahan, Shari B., Islam, Shahidul, Altshuler, Diana, Spiegler, Peter, Li, Wai Kin, Wang, Wai Man, Chen, Xian Jie Cindy
Publicado 2023

Low-Dose Tocilizumab With High-Dose Corticosteroids in Patients Hospitalized for COVID-19 Hypoxic Respiratory Failure Improves Mortality Without Increased Infection Risk

por Brosnahan, Shari B., Chen, Xian Jie Cindy, Chung, Juri, Altshuler, Diana, Islam, Shahidul, Thomas, Sarun V., Winner, Megan D., Greco, Allison A., Divers, Jasmin, Spiegler, Peter, Sterman, Daniel H., Parnia, Sam
Publicado 2021